Arrowhead Pharmaceuticals Inc (ARWR)
EBITDA Growth
0.54%
Quarterly · Period ending:
ARWR EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported0.54%period ending
Latest reported0.54%period ending
ARWR Quarterly EBITDA YoY % (-200.00% → 0.54%)
Year-over-year change
High-resolution chart · PNG
ARWR ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 0.5388% | |
| -127.0175% | |
| 138.5647% | |
| 141.9269% | |
| 9.5167% | |
| 444.8315% | |
| -14.8575% | |
| -53.3269% | |
| -72.8307% | |
| -307.9835% | |
| -255.9659% | |
| -23.0368% | |
| -36.7117% | |
| 17.977% | |
| 40.3174% | |
| -30.1239% | |
| -132.5064% | |
| 278.4601% | |
| -173.5657% | |
| -29.0297% | |
| -107.2935% | |
| -26.0974% | |
| -518.0351% | |
| -550.9589% | |
| -173.5234% | |
| -190% | |
| -129.6374% | |
| 207.8436% | |
| 232.9347% | |
| 267.0417% | |
| 195.6645% | |
| -9.2904% | |
| -223.9254% | |
| -180.8735% | |
| 7.6089% | |
| 51.8765% | |
| 75.4282% | |
| 75.8467% | |
| 26.0455% | |
| 22.4563% | |
| -21.4431% | |
| 29.8879% | |
| 25.2901% | |
| -22.4131% | |
| -22.7672% | |
| -169.797% | |
| -275.7996% | |
| -161.9887% | |
| -168.4694% | |
| -118.8944% | |
| -51.4985% | |
| -54.1201% | |
| 27.4596% | |
| -11.1751% | |
| -21.6434% | |
| -73.1633% | |
| -274.4525% | |
| -154.891% | |
| -9.7211% | |
| -29.3647% | |
| -28.8155% | |
| -165.6599% | |
| -64.5089% | |
| 33.5297% | |
| 35.1397% | |
| 153.6009% | |
| 76.0413% | |
| 70.628% | |
| 78.8243% | |
| 26.8683% | |
| -25.5907% | |
| 0.7061% | |
| 26.7421% | |
| 17.3962% | |
| -55.5467% | |
| -33.4742% | |
| -206.1514% | |
| -42.4786% | |
| -9.225% | |
| -366.7066% | |
| -61.7762% | |
| -278.7339% | |
| -147.3854% | |
| -27.87% | |
| -346.5776% | |
| -186.1875% | |
| -1,003.1895% | |
| -7,998.1538% | |
| -4,335.7068% | |
| -1,812.7453% | |
| -365.7636% | |
| 98.6615% | |
| 69.4535% | |
| -24.1705% | |
| -18.8774% | |
| -4,304.1289% | |
| -182.646% | |
| 5.864% | |
| 22.13% | |
| -13.8809% |